| Tag | Content |
|---|
EnhancerAtlas ID | HS197-12146 |
Organism | Homo sapiens |
Tissue/cell | ZR75-30 |
Coordinate | chr2:160750600-160752670 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CEBPA | MA0102.3 | chr2:160752513-160752524 | TATTATGCAAT | - | 6.02 | | NFE2L1 | MA0089.2 | chr2:160751777-160751792 | TTTGCTGTGTCATAG | - | 6.13 | | REL | MA0101.1 | chr2:160752101-160752111 | GGAAATCCCC | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_59424 | chr2:160734230-160762132 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr2 | 160752028 | 160752468 | | chr2 | 160750687 | 160752000 | | chr2 | 160752173 | 160752279 | | chr2 | 160752318 | 160752666 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I159895 | chr2 | 160752173 | 160752279 |
|
Enhancer Sequence | TTGGAGAGGA AGTTGGGGAA AAGAGAGTTA AAAACTGGGT AGTCAGCGTC AGGTGGCTAA 60
TTTCTAAAAC TGTTTTTAAA AGAAACGTTG TTTAGAATAC AATATCCGAG TGTAGGAATT 120
CAGAGCATGG GTGCTGTCAG GTCTGGATAT GAATGCTGGC TCCCTGCTAA CCCACTGTTT 180
GCCTGTGGGC TAGCTATCCA ACCTCTAGTA GCCTCTGTTT CTGCTTTTGC AAACTGGGGA 240
TAGCGTTCAG TGATCAACCA TGTGAAGCTT CACTTACTGT GGTGTGATGA GGCGCTGAAA 300
GAGCCTGGCT TGATCAGGTG AGGGTCTACT AACTCTGCTG TGGGCCGCAG AGCACTTCAC 360
CAGAAAGGGT GCCCTGGCTG AGGTTACATT TACCTCTATT TTCTTTTCTT TAGAAAGTGT 420
TGGAGCCAGA AAAATTCCTT GGAACCACTG AGGGTGGGTG TGGACTTTGG AACCACCTGC 480
GGCATTAGAA AGATGGACAA ATAGTCCCAT TGTTCAGAGA CTGGAGGTAG AATTGAGACT 540
GTGGTTTTTG AGGAAGTAAA AGGAAGAGCT GCTGAATTTC TGAGCAGATT CTTGGGAAGG 600
TACAAGGCAT GGTAATTTGG GGTGTGAAAG AAGCAGCAGC TTCAATGGGG CAGTCATGTG 660
ACCGGCGGGG GGCCAGTGAG GTAGTAGACA TAGCTTTTAC TTCAATCATT TTCCCTGGTA 720
CATGGGGAGG AACTGAAAAG TGATTCCAAC CTCAAATATG CCTGGAAATG CTGGAAAGAA 780
TGTTTGATAC TTATATCAAT ACTAATTCTC TTGGAAAGGT GTTTTTATAG AACAGCTATC 840
CCTGTATCCC TGTCACAATT TGCCAAAACC TCGGTCCACA ATTTGCTAAA AACCTCAGTC 900
ATTAACAGAT CAAATAATGG CCATTAGGTA AATCATAGTA ATCAGATCTT ATCACCGTTT 960
ACCAGGCAAT TAGGGTTCCT CCAAATGTCT CACAGATTTG CTTAAAAGTG TGCTTAAGAC 1020
AGTATTTGAT TCTACTTTCT TTTCCTCCAG TGTCCGTCTA ACTAAAGTGT GAGGCCATTT 1080
AACAGCTTAG AATGTAATAA GCAGACCTAT AGCAAAAGGT AATAATAATC TGGATGCTTT 1140
TCTTGGCAAA TAGTCTTTTA AAGATCACTG GTTTTGTTTT GCTGTGTCAT AGAAACAGTT 1200
TTCAAAAGCG TACTTCTGTT AAAGAGTGTG TTGACCTTAT ATTTTATAAG GATTCTGCTT 1260
ATTACCTATG TTTCAGTTTA ACCGCATCAA AACCCCCCAA TAGCTCATGA CCAGTTTCTT 1320
TTCCCATATT ACAAACCTAA GAGGACAGTC CCTGAACACA AAGACTGTTC CTTGTAGAGC 1380
CATCAGTTTT CTTTTCTAAA ACCTTTGATT TTTGGAATAC AAAGTGCCTT GGTATACATT 1440
TCTGTCATTT GTTCTTTATC ATAAACCTGT GAGATCATAG GGGAGGTATT ATACTTGTCT 1500
GGGAAATCCC CATTTTTGCA GAGTAGTCAA GTGATACATT CAGGCACTCA GCTGCAAGTG 1560
ACAGGAATGA GAATGGGCTC TCTCTGATTA GACTCTTGAC CTATAAGGAC AACTTGTGAC 1620
ATCAGCGGGT GCCTTCTCAA GTTTCAAGTT AAATTTCATA GCTCAAAGCT GGGCTTCAAT 1680
TAATAAGCTC TCTAAGTCAC AATATATGCT TTGAAGAATG ATAAGCATAC AACCACCACA 1740
CCAGAAGCAG CTAAATTACG CTAACTATTC ACTAAGCATT TTGTTCCCAC ACATTCTTTG 1800
CTGATGCTGG CCTCTTACAC ACCATGGGCT TCCTTAGCAA GACAGACTTT CCTGGGAAGA 1860
ATCTTCTCTG AATGTGCAAA TTTATGATGA TAGCATCCTT AAAACAACAG CTTTATTATG 1920
CAATAGTTAC AAATTTGTGA GATGAGGTGA TTATGCAGAA AACTAGCAAA TTAATGTCAT 1980
CAGTAACATG AGACAAAATA GTTTCAATGG ATAAAGAGGT TGTTGGCAGG CTTCTAAGAG 2040
TTGCCCAGAA TTCTGATAGT TCTGCAGCCA 2070
|
